AMD up six and a half percent while the rest of the chip sector bleeds — that's not a sector story, that's a name story.

AMD up six and a half percent while the rest of the chip sector bleeds — that's not a sector story, that's a name story.

AMD at five-fourteen, up six-point-five. Broadcom down nearly six to three-ninety-three — sharpest drop on the board. Oracle off three-point-six-five to one-fifty. Salesforce down two-point-five-six to one-ninety-six. One sector, four different stories, one clear winner.

Eli Lilly down two-point-four to eleven-eighty. Pharma rotating out while semis sorted themselves — capital moved, not disappeared. Intel down one-point-nine-seven to one-oh-two-fifty. Quietly bleeding while AMD takes the headline. Amazon off less than one percent to two-sixty-two. Meta down under a point to five-eighty-nine. Large-cap tech soft, not broken. Exxon up zero-point-nine-four to one-sixty — energy holding while growth wobbled.

Futures are flat with a lean south. SPY off zero-point-two. QQQ off zero-point-fourteen. Small caps bucked the drift — IWM up half a point. Dow and S-P in line. VIX sitting at fourteen-twenty-five, calm. Gold up one-point-five-seven — someone somewhere is hedging something.

No economic data on the calendar. Nothing scheduled. The macro is quiet. The moves you saw today were pure positioning.

Earnings on deck: Allarity Therapeutics, ticker ALLR, consensus at negative twenty-five-point-five cents. Athira Pharma, ticker ATHR, consensus at negative twelve-point-two cents. Both early-stage biotech, both expected to lose money — the only question is by how much.

Asian markets were unavailable overnight. No read from that direction.

Bottom line: AMD separated from the pack in a sector that otherwise got hit. Broadcom took the worst of it. Gold caught a bid. Small caps outperformed large. The market wasn't collapsing — it was sorting.

Numbers don't lie. People do. Trade accordingly.